Dr. Melissa Leigh Larson, MD

Dr. Larson practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Larson's NPI, 1912967688, was assigned on March 25, 2006. Dr. Larson graduated from Rush Medical College in 2000. Dr. Larson holds Illinois license 036108941.

Dr. Larson's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Larson's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Larson is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Larson to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Larson practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Larson's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Larson is board certified in hematology by the American Board of Internal Medicine. Dr. Larson is licensed in Illinois.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Larson treats.

CMS data shows 745 Medicare services from Dr. Larson across 8 procedure codes in 2024, for 339 Medicare patients. Medicare paid $69,054 for them.

CMS counts 339 Medicare patients who saw Dr. Larson in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Larson's median patient age at 70, with 58% women.

In 2024, Dr. Larson wrote 1,192 Medicare Part D claims for 201 patients. 59% of them were for generic drugs. CMS names the drug for 972 of them, across 30 drugs with 11 or more claims each, at $6,082,664 in total drug cost. In 2023, CMS named 1,038 claims across 30 drugs.

Dr. Larson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Larson, published from 2011 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal, Murine-Derived. Dr. Larson has published most often in Blood Adv. Dr. Larson's most frequent co-authors are Stephanie Gregory, MD, Ivy Elizabeth Abraham and Jessica Kaplan Altman, MD.

Dmand AI links Dr. Larson to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Leukemia, Myeloid, Acute and Leukemia, Myeloid.

CMS Open Payments shows 23 general payments to Dr. Larson from 3 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 86% of the total. Abbvie Inc. paid the most, $4,301.

Dmand AI lists 1 award for Dr. Larson, most recently CMS Stage 1 EHR in 2013.

Dr. Larson graduated from Rush Medical College in 2000. Dr. Larson is a member of ASCO.

Dr. Larson is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.